<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02352610</url>
  </required_header>
  <id_info>
    <org_study_id>2015-239</org_study_id>
    <nct_id>NCT02352610</nct_id>
  </id_info>
  <brief_title>A Prospective Randomized Trial Comparing Standard Ligament Reconstruction Tendon Interposition (LRTI) VS Ligament Reconstruction Tendon Interposition (LRTI) With an Interference Screw for Thumb Carpometacarpal Arthritis - Pilot Study</brief_title>
  <official_title>A Prospective Randomized Trial Comparing Standard Ligament Reconstruction Tendon Interposition (LRTI) VS Ligament Reconstruction Tendon Interposition (LRTI) With an Interference Screw for Thumb Carpometacarpal Arthritis - Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Andrew Trenholm</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nova Scotia Health Authority</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Prospective Randomized Trial Comparing Standard Ligament Reconstruction Tendon&#xD;
      Interposition (LRTI) VS Ligament Reconstruction Tendon Interposition (LRTI) with an&#xD;
      interference screw for thumb carpometacarpal arthritis&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will be a prospective randomized trial done in a single academic center. The&#xD;
      patients who meet the inclusion criteria and agree to participate in the trial will be&#xD;
      scheduled for a first CMC joint procedure. The procedure, standard LRTI or LRTI with a&#xD;
      biotenodesis screw, will be allocated in a randomized fashion in the operating room using a&#xD;
      sealed opaque envelope. After the surgery the patient will be placed in a spica splint for&#xD;
      1-2 weeks. Following suture removal, a thumb spica cast will be applied for immobilization&#xD;
      for a total of 6 weeks of post-operative immobilisation.&#xD;
&#xD;
      The potential population for this study will include all patients with first carpometacarpal&#xD;
      joint arthritis that have failed a conservative treatment. The primary outcome will be the&#xD;
      thumb subsidence measured as the percentage of trapezial height, which correlates with&#xD;
      stability. Subsidence will be measured on stress x-ray under a standard pinch load. Secondary&#xD;
      outcomes will be function measured in 4 different ways: the range of motion compared to the&#xD;
      contralateral side, pinch and grip strength compared to the other side, the Disabilities of&#xD;
      the Arm Shoulder and Hand (DASH) score and the pain score on a visual analogue scale.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Actual">April 30, 2018</completion_date>
  <primary_completion_date type="Actual">February 22, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Subsidence of CMC joint</measure>
    <time_frame>6 weeks, 3 months, 6 months, 1 year, 2 years</time_frame>
    <description>Measurement of trapezial height as a percentage of pre-operative height</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>EQ-5D Health Questionnaire Score</measure>
    <time_frame>Baseline, 6 weeks, 3 months, 6 months, 1 year, 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DASH questionnaire score</measure>
    <time_frame>Baseline, 6 weeks, 3 months, 6 months, 1 year, 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Grip strength as measured by dynamometer</measure>
    <time_frame>Baseline, 3 months, 6 months, 1 year, 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pinch strength as measured by dynamometer</measure>
    <time_frame>Baseline, 3 months, 6 months, 1 year, 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opposition as measured by goniometer</measure>
    <time_frame>Baseline, 3 months, 6 months, 1 year, 2 years</time_frame>
    <description>thumb range of motion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radial abduction as measured by goniometer</measure>
    <time_frame>Baseline, 3 months, 6 months, 1 year, 2 years</time_frame>
    <description>thumb range of motion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Palmar abduction as measured by goniometer</measure>
    <time_frame>Baseline, 3 months, 6 months, 1 year, 2 years</time_frame>
    <description>thumb range of motion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain score on the visual analogue scale</measure>
    <time_frame>Baseline, 2 weeks, 6 weeks, 3 months, 6 months, 1 year, 2 years</time_frame>
    <description>visual analogue scale</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Number of participants with Adverse Events</measure>
    <time_frame>Baseline, 2 weeks, 6 weeks, 3 months, 6 months, 1 year, 2 years</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>LRTI without a Biotenodesis Screw</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ligament Reconstruction Tendon Interposition without a Biotenodesis Screw</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LRTI with Biotenodesis Screw</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ligament Reconstruction Tendon Interposition with Biotenodesis Screw</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>LRTI</intervention_name>
    <arm_group_label>LRTI with Biotenodesis Screw</arm_group_label>
    <arm_group_label>LRTI without a Biotenodesis Screw</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Biotenodesis Screw</intervention_name>
    <arm_group_label>LRTI with Biotenodesis Screw</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  First CMC primary osteoarthritis refractory to conservative treatment&#xD;
&#xD;
          -  Patient &gt;age 18&#xD;
&#xD;
          -  Able to read and understand English&#xD;
&#xD;
          -  Available for 2 year follow up&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inflammatory Arthritis&#xD;
&#xD;
          -  Active infection in the first CMC joint&#xD;
&#xD;
          -  Concomitant neuropathy&#xD;
&#xD;
          -  Previous surgical procedure on the thumb&#xD;
&#xD;
          -  Active or status post CRPS&#xD;
&#xD;
          -  Severe ¨Z ¨deformity that requires palmar plate advancement&#xD;
&#xD;
          -  Unwilling to participate in a research project&#xD;
&#xD;
          -  Contralateral first CMC joint surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Queen Elizabeth II Health Sciences Centre</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3H3A7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>January 8, 2015</study_first_submitted>
  <study_first_submitted_qc>January 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 2, 2015</study_first_posted>
  <last_update_submitted>July 16, 2018</last_update_submitted>
  <last_update_submitted_qc>July 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Nova Scotia Health Authority</investigator_affiliation>
    <investigator_full_name>Andrew Trenholm</investigator_full_name>
    <investigator_title>Orthopaedic Surgeon</investigator_title>
  </responsible_party>
  <keyword>carpometacarpal joints</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

